Continence
(Jun 2022)
297 LONG-TERM EFFICACY AND SAFETY OF VIBEGRON FOR OVERACTIVE BLADDER SYNDROME IN PATIENTS ≥65 YEARS OLD: ANALYSIS FROM THE EMPOWUR EXTENSION TRIAL
- D Staskin,
- J Frankel,
- S Varano,
- H Greene,
- E Thomas
Affiliations
- D Staskin
- Tufts University School of Medicine
- J Frankel
- Seattle Urology Research Center
- S Varano
- Clinical Research Consulting
- H Greene
- Urovant Sciences
- E Thomas
- Urovant Sciences
- Journal volume & issue
-
Vol. 2
pp.
1
– 2
WeChat QR code